Ginkgo biloba and blood markers in mild cognitive impairment
Part of Brain & nervous system, Mental health clinical trials.
This trial studies whether Ginkgo biloba, a natural supplement, can affect certain blood markers in people with mild cognitive impairment (MCI). It may help show how the supplement works in the body and whether it could be a helpful option for early memory problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years old or older.
- You need a diagnosis of mild cognitive impairment (MCI) — a slight but noticeable decline in memory or thinking.
- Your doctor must recommend treatment with Ginkgo biloba extract.
- You cannot be taking certain dementia medications (like donepezil, rivastigmine, or galantamine).
- You cannot have bleeding disorders or be taking blood thinners or similar medications.
- You must be able to take the supplement without lactose issues (no severe lactose intolerance).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies EGb 761 to see if it can improve symptoms in people with mild cognitive impairment (early memory/thinking changes) who also have signs of brain blood vessel disease. It may help by targeting the brain changes seen on scans.
This Phase 1 study tests whether Centella asiatica (a plant-based supplement) is safe and reaches its intended target in people with mild cognitive impairment or early Alzheimer’s disease. It also checks how it affects memory-related brain measures like MRI scans, which is why multiple scans are required.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.